ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Sophia G. Kisling

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3287-1495; OpenAlex author ID A5089764300. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217097 ↗
A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-23-0825 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pranita Atri · 2 shared papers, 2023–2024 · strength 0.39
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
- Paper A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Du… DOI 10.1158/1078-0432.ccr-23-0825 ↗
Jesse L. Cox · 2 shared papers, 2023–2024 · strength 0.39
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
- Paper A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Du… DOI 10.1158/1078-0432.ccr-23-0825 ↗
Ashu Shah · 2 shared papers, 2023–2024 · strength 0.39
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
- Paper A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Du… DOI 10.1158/1078-0432.ccr-23-0825 ↗
Surinder K. Batra · 2 shared papers, 2023–2024 · strength 0.39
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
- Paper A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Du… DOI 10.1158/1078-0432.ccr-23-0825 ↗
Rahat Jahan · 1 shared paper, 2024 · strength 0.20
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
Palanisamy Nallasamy · 1 shared paper, 2024 · strength 0.20
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
Sushil Kumar · 1 shared paper, 2024 · strength 0.20
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
Muzafar Ahmad Macha · 1 shared paper, 2024 · strength 0.20
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
Moorthy Palanimuthu Ponnusamy · 1 shared paper, 2024 · strength 0.20
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097 ↗
Lynette M. Smith · 1 shared paper, 2023 · strength 0.19
- Paper A Novel HOXA10-Associated 5-Gene-Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Du… DOI 10.1158/1078-0432.ccr-23-0825 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.